News

AG Mednet has announced the availability of new capabilities to enable sponsors, CROs and core laboratories to take delivery of electronic trial data

Clinverse, Inc. has established a strategic partnership with Datatrak.

AG Mednet announced the availability of new capabilities to enable sponsors, CROs and core laboratories to take delivery of electronic trial data

The first conference I?ll attend this year is in two weeks in Philadelphia, on Data Disclosure and Transparency.

Many biopharmaceutical enterprises and CROs are trying to establish solid risk assessment techniques and infrastructures to enhance clinical trial data quality, strategy, and reduce monitoring costs

With all of the buzz and excitement around risk-based monitoring, one might expect that the broad adoption of this emerging clinical research paradigm is well under way.

New SMART feature provides CRAs with efficient control of modification requests, eliminates delays and regulatory concerns over site staff activation and deactivation

Exco InTouch announced the successful completion of an independent audit

Exco InTouch announced that it has successfully undergone and completed an independent audit to assess compliance utilizing the National Institute of Standards and Technology guidelines for Health Insurance Portability and Accountability Act security.

Quintiles was named to the CSO40, which is for security professionals in a broad range of disciplines.

Quintiles' Trusted Cloud Services Model Recognized in CSO40

BioClinica and CCBR-SYNARC have signed an agreement to merge their companies

Merger to Create Leading Provider of Specialty Outsourced Clinical Services

The Impact of Outsourcing Partnerships on Clinical Trial Optimization

Results from a Multicenter Clinical Trial Using a Quality by Design Methodology, Risk-Based Monitoring and Real-Time Direct Data Entry

MCC has 100 different metrics relating to clinical trials, from timeliness and cycle time metrics to quality, efficiency, and cost metrics.

As expected, the Food and Drug Administration approved only 27 new molecular entities (NMEs) in 2013.

Significant Enhancements Demonstrate MedNet's Commitment to Efficiency and Ease-of-Use

EMA webminars on eSignatures

Gastrointestinal therapeutics market to decline from $6.8 billion in 2012 to $6.6 billion by 2019

Further details about the 17th International Conference on Pharmaceutical Medicine (ICPM 2014) have been unveiled.

The European Forum for GCP (EFGCP) has published its final report, ?Indemnity Schemes for Clinical Trials: A Societal Obligation??

attend the 17th International Conference on Pharmaceutical Medicine (ICPM 2014). It is an international forum for pharmaceutical physicians, pharmaceutical medicine professionals and clinical research experts world-wide who are involved in the discovery, development, evaluation, registration, monitoring and marketing of medicines.

The U.S. Food and Drug Administration opened the door to a new era of clinical trial management last summer when it released guidance for industry on clinical trial oversight and called for expanded use of risk-based monitoring.

51% of the overall gastrointestinal therapeutic pipeline is in Phase II to Phase III development, of which 19 molecules are indicated for the treatment of Irritable Bowel Syndrome, 48 for ulcerative colitis, and 41 for Chron?s Disease.

New report shows life sciences sector using benefits to win talent war

Salaries in the U.K. life sciences sector are static, but the range of non-monetary benefits being offered to staff is improving fast, according to a new salary survey.

With the upcoming release of Wingspan eTMF 2.0, Wingspan Technology is holding an exclusive preview webinar